Research ArticleArticle
Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events
Caitrin M. Coffey, Michael D. Richter, Cynthia S. Crowson, Matthew J. Koster, Kenneth J. Warrington, Steven R. Ytterberg and Ashima Makol
The Journal of Rheumatology June 2019, jrheum.181397; DOI: https://doi.org/10.3899/jrheum.181397
Caitrin M. Coffey
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
Michael D. Richter
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
Cynthia S. Crowson
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
Matthew J. Koster
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
Kenneth J. Warrington
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
Steven R. Ytterberg
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
Ashima Makol
From the Division of Rheumatology, Department of Internal Medicine, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA. C.M. Coffey, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; M.D. Richter, MD, Department of Internal Medicine, College of Medicine and Science, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, College of Medicine and Science, Mayo Clinic; M.J. Koster, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; K.J. Warrington, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; S.R. Ytterberg, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic; A. Makol, MD, Division of Rheumatology, College of Medicine and Science, Mayo Clinic. Address correspondence to Dr. A. Makol, Assistant Professor of Medicine, Consultant, Division of Rheumatology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905, USA. E-mail: makol.ashima@mayo.edu. Accepted for publication June 4, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events
Caitrin M. Coffey, Michael D. Richter, Cynthia S. Crowson, Matthew J. Koster, Kenneth J. Warrington, Steven R. Ytterberg, Ashima Makol
The Journal of Rheumatology Jun 2019, jrheum.181397; DOI: 10.3899/jrheum.181397
Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events
Caitrin M. Coffey, Michael D. Richter, Cynthia S. Crowson, Matthew J. Koster, Kenneth J. Warrington, Steven R. Ytterberg, Ashima Makol
The Journal of Rheumatology Jun 2019, jrheum.181397; DOI: 10.3899/jrheum.181397